Recommended

GSK appoints new CEO
New webinar | Addressing the time-to-result challenge posed by short shelf-life radiopharmaceuticals, register today
Genmab acquires biotech Merus for $8bn
US FDA licensing first for IL-23 inhibitor to treat paediatric psoriasis
Teva makes progress on API business divestment
Takeda to move away from cell therapy
news

Research organisation calls for urgent action to tackle obesity

0
SHARES

Posted: 19 May 2016 | | No comments yet

The European Association for the Study of Obesity (EASO) has issued a warning urging for action to tackle the regions rising obesity epidemic.

Research organisation calls for urgent action to tackle obesity

The European Association for the Study of Obesity (EASO) has issued a warning urging for action to tackle the regions rising obesity epidemic.

 

Reserve your FREE place

 


Address the time-to-result challenge posed by short shelf-life radiopharmaceuticals.

20 November 2025 | 3:00 PM GMT | FREE Virtual Panel Discussion

This webinar showcases the Growth Direct System; an RMM (Rapid Microbial Method) that improves on traditional membrane filtration, delivering increased accuracy, a faster time to result, enhanced data integrity compliance, and more control over the manufacturing process.

Key learning points:

  • Understand the benefits of full workflow microbiology quality control testing automation in radiopharmaceutical production
  • Learn about ITM’s implementation journey and considerations when evaluating the technology
  • Find out how the advanced optics and microcolony detection capabilities of Growth Direct® technology impact time to result (TTR).

Don’t miss your chance to learn from experts in the industry – Register for FREE

 

Research organisation calls for urgent action to tackle obesity

EASO, the organisation responsible for research into obesity in Europe, has warned that unless something is done quickly to tackle the region’s rising obesity epidemic, it will have a devastating effect on healthcare costs and productivity.

Today’s warning comes ahead of various events, hosted by EASO and its member associations in 32 European countries, highlighting the situation and creating greater awareness and understanding of obesity. The events will take place on European Obesity Day this Saturday (21 May).

According to World Health Organisation, obesity is one of the greatest public health challenges of the 21st century. Its prevalence has tripled in many countries in Europe since the 1980s.

Obesity costs European countries €70 billion in healthcare and lost productivity

According to EASO, obesity is now costing European countries more than €70 billion in healthcare and lost productivity.

Two reports in the medical journal, the Lancet[i], also underlined the sheer magnitude of the global obesity epidemic and have highlighted the huge rise in type 2 diabetes as a result.
Type 2 diabetes, cardiovascular disease, and certain forms of cancer, are among a number of non-communicable diseases (NCDs) that are all a greater risk to people with excess weight.

“Obesity is a complex and chronic disease with numerous causes, many of which are beyond an individual’s control”

“Obesity is a complex and chronic disease with numerous causes, many of which are beyond an individual’s control,” says EASO President, Professor Hermann Toplak. “The causes can range from genetic and endocrine conditions to environmental factors, such as stress, diet and increasingly sedentary working patterns.

“A healthier lifestyle, including a healthy diet and regular physical activity can help maintain a normal weight. However, obesity is a chronic disease and should be recognised and treated as such. Accepting and supporting people with obesity will help them seek the help and treatment they need,” he added.

Reference

[i] Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. The Lancet, Volume 387, No. 10026, p1377–1396, 2 April 2016 http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30054-X/abstract

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants, The Lancet Volume 387, No. 10027, p1513–1530, 9 April 2016 http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)00618-8/abstract

Share via
Share via